» Authors » Chrisoula D Scopa

Chrisoula D Scopa

Explore the profile of Chrisoula D Scopa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 949
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Makatsoris T, Tsamandas A, Strimpakos A, Alexopoulou Z, Dionysopoulos D, Pervana S, et al.
Anticancer Res . 2016 Apr; 36(4):1581-90. PMID: 27069134
Background: Gastric cancer is a relatively common malignancy. Recently, the presence of the human epidermal growth factor receptor 2 (HER2) was identified as a molecular target in a proportion of...
2.
Papaxoinis G, Kotoula V, Alexopoulou Z, Kalogeras K, Zagouri F, Timotheadou E, et al.
PLoS One . 2015 Oct; 10(10):e0140293. PMID: 26452060
Background: The PI3K-AKT pathway is frequently activated in breast cancer. PIK3CA mutations are most frequently found in the helical (exon 9) and kinase (exon 20) domains of this protein. The...
3.
Linardou H, Kalogeras K, Kronenwett R, Alexopoulou Z, Wirtz R, Zagouri F, et al.
Anticancer Res . 2015 Jul; 35(7):4023-36. PMID: 26124351
Background: Vascular endothelial growth factor C (VEGFC) and vascular endothelial growth factor receptor 1 (VEGFR1) mRNA overexpression has recently been shown to have strong predictive and prognostic value in patients...
4.
Pectasides D, Karavasilis V, Papaxoinis G, Gourgioti G, Makatsoris T, Raptou G, et al.
BMC Cancer . 2015 May; 15:384. PMID: 25956750
Background: The aim of the trial was to compare two active adjuvant chemotherapy regimens in patients with early stage colorectal cancer (CRC). Methods: Patients were assigned to oxaliplatin, leucovorin and...
5.
Kourea H, Nikolaou M, Tzelepi V, Adonakis G, Kardamakis D, Tsapanos V, et al.
Anticancer Res . 2015 Apr; 35(4):2321-31. PMID: 25862896
Background/aim: The Akt/mTOR and MAPK pathways are frequently activated in various tumor types but data on endometrial carcinoma are limited. The aim of the present study was to investigate the...
6.
Kourea H, Kotoula V, Koutras A, Alexopoulou Z, Papaspirou I, Skarlos D, et al.
Histol Histopathol . 2015 Mar; 30(9):1129-41. PMID: 25807307
Background: Metronomic taxane administration has putative antiangiogenic properties. Herein, we examined the baseline tumor angiogenic profile of patients with metastatic breast carcinoma (MBC) in a prospective-retrospective translational research study. The...
7.
Kourea H, Zolota V, Scopa C
Curr Mol Pharmacol . 2015 Jan; 7(1):4-21. PMID: 25563853
Breast carcinoma is currently considered as a group of diseases, differing not only in histopathologic phenotype, as indicated by histologic type and grade, but also in their protein, genetic and...
8.
Bouchagier K, Assimakopoulos S, Karavias D, Maroulis I, Tzelepi V, Kalofonos H, et al.
In Vivo . 2014 May; 28(3):315-26. PMID: 24815833
Background: Occludin and claudins are integral constituents of tight junction proteins and are de-regulated in various malignancies, including hepatocellular carcinoma (HCC). This study investigated whether expression of claudins 1, 4,...
9.
Nikolaou M, Kourea H, Tzelepi V, Adonakis G, Scopa C, Tsapanos V, et al.
J BUON . 2014 Mar; 19(1):198-202. PMID: 24659664
Purpose: Previous studies have shown that elevated preoperative serum CA 125 levels strongly correlate with various clinical and pathological variables and prognosis of patients with endometrial carcinoma (EC). The aim...
10.
Pentheroudakis G, Kotoula V, Eleftheraki A, Tsolaki E, Wirtz R, Kalogeras K, et al.
PLoS One . 2013 Aug; 8(7):e70634. PMID: 23923010
Background: Discrepant data have been published on the incidence and prognostic significance of ESR1 gene amplification in early breast cancer. Patients And Methods: Formalin-fixed paraffin-embedded tumor blocks were collected from...